Prognostic score for patients with advanced melanoma treated with ipilimumab
详细信息 查看全文
- 作者：Stefan Diema ; 1 ; Benjamin Kasendaa ; 1 ; Juan Martin-Liberala ; b ; Alexander Leea ; Dharmisha Chauhana ; Martin Gorea ; James Larkina ; james.larkin@rmh.nhs.uk" class="auth_mail" title="E-mail the corresponding author
- 关键词：Metastatic Melanoma ; Ipilimumab ; Risk Factors ; Prognostic Score
- 刊名：European Journal of Cancer
- 出版年：2015
- 出版时间：December 2015
- 年：2015
- 卷：51
- 期：18
- 页码：2785-2791
- 全文大小：343 K
文摘
- class="listitem" id="list_ulist0010">
- class="label">•
We evaluated patients with metastatic melanoma treated with ipilimumab.
- class="label">•
Lactate dehydrogenase, Eastern Cooperative Oncology Group and number of involved organs are the most important adverse factors.
- class="label">•
We propose an easy-to-apply prognostic score that consists of three risk groups.
- class="label">•
This could be helpful for counselling patients and guiding treatment decision.